Page 5 - Nasdaq Podd News Today

Dupont Capital Management Corp lessened its holdings in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 7.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,500 shares of the medical instruments supplier’s stock after selling 197 shares […]

Insulet (NASDAQ:PODD – Free Report) had its price target decreased by Morgan Stanley from $208.00 to $185.00 in a research report sent to investors on Friday, Marketbeat Ratings reports. Morgan Stanley currently has an equal weight rating on the medical instruments supplier’s stock. A number of other analysts have also commented on the company. UBS […]

Insulet Co. (NASDAQ:PODD – Get Free Report) gapped up prior to trading on Monday . The stock had previously closed at $159.49, but opened at $163.88. Insulet shares last traded at $165.23, with a volume of 199,835 shares trading hands. Analysts Set New Price Targets A number of equities analysts have commented on the stock. […]

FDx Advisors Inc. raised its position in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 28.1% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,017 shares of the medical instruments supplier’s stock after acquiring an additional 223 shares during the […]

Insulet (NASDAQ:PODD – Get Free Report) had its price target decreased by equities research analysts at Morgan Stanley from $208.00 to $185.00 in a research report issued on Friday, FlyOnTheWall reports. Morgan Stanley’s price objective would indicate a potential upside of 12.90% from the stock’s current price. Several other analysts have also recently issued reports […]

Cabot Wealth Management Inc. trimmed its position in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 3.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,654 shares of the medical instruments supplier’s stock after selling 360 shares during the quarter. Cabot Wealth […]

Insulet (NASDAQ:PODD – Free Report) had its price target lowered by Raymond James from $299.00 to $228.00 in a research note released on Friday morning, Benzinga reports. The brokerage currently has an outperform rating on the medical instruments supplier’s stock. Several other research analysts have also recently weighed in on the company. StockNews.com initiated coverage […]

State Board of Administration of Florida Retirement System decreased its position in Insulet Co. (NASDAQ:PODD – Free Report) by 1.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 78,435 shares of the medical instruments supplier’s stock after selling 1,440 […]

Moody National Bank Trust Division grew its holdings in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 1.8% in the second quarter, according to its most recent filing with the SEC. The firm owned 3,544 shares of the medical instruments supplier’s stock after acquiring an additional 64 shares during the quarter. Moody National Bank […]

Stephens Investment Management Group LLC trimmed its position in Insulet Co. (NASDAQ:PODD – Free Report) by 27.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 46,453 shares of the medical instruments supplier’s stock after selling 17,142 shares during the quarter. Stephens Investment Management Group […]